Clinical Study
Treatment Challenges in Pediatric Stroke Patients
Table 3
The medication in acute treatment.
| | Medication | Acute ischemic stroke n(%) | Sinovenous thrombosis n (%) | Hemorrhagic stroke n (%) |
| | Unfractionated heparin | 4 (%4.3) | 2 (%25) | — | | TPA+ Unfractionated Heparin | 2 (%2.2) | — | — | | Warfarin | 1 (%1.1) | — | — | | K-Vitamin | — | — | 2 (%28.6) |
|
|
Tissue plasminogen activator.
|
